Telix Pharmaceuticals Limited (TLX) Reports Q2 results

Go back to Telix Pharmaceuticals Limited (TLX) Reports Q2 results
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.85 +0.30 (2.84%)
Previous Close $10.55    52 Week High $2.18 
Open $10.80    52 Week Low $0.30 
Day High $10.88    P/E N/A 
Day Low $10.79    EPS $-3.32 
Volume 128,935